Osaka Metropolitan University Hospital is a university hospital in Japan. It's located in Abeno-ku, Osaka, and affiliated with Osaka Metropolitan University.

There are 980 beds in Osaka city University Hospital.

During the past decade, Osaka city University Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka city University Hospital" #1 collaborator was "Japan Blood Products Organization" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Osaka city University Hospital" are "Advanced Hepatocellular Carcinoma" (1 trials), "Cancer, Hepatocellular" (1 trials), "Heart Failure" (1 trials), "Preeclampsia" (1 trials) and "Tachycardia, Ventricular" (1 trials). Many other conditions were trialed in "Osaka city University Hospital" in a lesser frequency.

Most popular intervention types in "Osaka city University Hospital" are "Drug" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antithrombin gamma" (1 trials), "Placebo" (1 trials), "St. Jude Medical Optisure Lead" (1 trials), "TAC-101" (1 trials) and "TACE" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osaka city University Hospital" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Osaka city University Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Osaka city University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Osaka city University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".